These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9255709)

  • 41. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV; Couet W; Olivier JC
    Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres.
    Presmanes C; de Miguel L; Espada R; Alvarez C; Morales E; Torrado JJ
    J Microencapsul; 2011; 28(8):791-8. PubMed ID: 21967461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs.
    Almeida AJ; Alpar HO; Brown MR
    J Pharm Pharmacol; 1993 Mar; 45(3):198-203. PubMed ID: 8097777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
    Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The formation and characterization of hydrocortisone-loaded poly((+/-)-lactide) microspheres.
    Cavalier M; Benoit JP; Thies C
    J Pharm Pharmacol; 1986 Apr; 38(4):249-53. PubMed ID: 2872287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New drug salt formation in biodegradable microspheres.
    Al-Maaieh A; Flanagan DR
    Int J Pharm; 2005 Oct; 303(1-2):153-9. PubMed ID: 16125886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SPHRINT - Printing Drug Delivery Microspheres from Polymeric Melts.
    Shpigel T; Uziel A; Lewitus DY
    Eur J Pharm Biopharm; 2018 Jun; 127():398-406. PubMed ID: 29578074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of gamma-sterilization process on PLGA microspheres loaded with insulin-like growth factor-I (IGF-I).
    Carrascosa C; Espejo L; Torrado S; Torrado JJ
    J Biomater Appl; 2003 Oct; 18(2):95-108. PubMed ID: 14621336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
    Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
    Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA-PLA core/shell microspheres.
    Zhao H; Wu F; Cai Y; Chen Y; Wei L; Liu Z; Yuan W
    Int J Pharm; 2013 Jun; 450(1-2):235-40. PubMed ID: 23624084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats.
    Montisci MJ; Dembri A; Giovannuci G; Chacun H; Duchêne D; Ponchel G
    Pharm Res; 2001 Jun; 18(6):829-37. PubMed ID: 11474788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subcutaneous absorption kinetics and local tissue distribution of interferon and other solutes.
    Cross SE; Roberts MS
    J Pharm Pharmacol; 1993 Jul; 45(7):606-9. PubMed ID: 8105053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of a multitracer technique for the studies of the uptake and retention of trace elements in rats.
    Hirunuma R; Endo K; Yanaga M; Enomoto S; Ambe S; Tanaka A; Tozawa M; Ambe F
    Appl Radiat Isot; 1997 Jun; 48(6):727-33. PubMed ID: 9204524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral particulate delivery: status and future trends.
    Chen H; Langer R
    Adv Drug Deliv Rev; 1998 Dec; 34(2-3):339-350. PubMed ID: 10837685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of in vitro and in vivo labeling of virus-induced L-cell interferon.
    Stancek D; Golgher RR; Paucker K
    J Gen Physiol; 1970 Jul; 56(1):134-48. PubMed ID: 19873663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Forms and Methods for Interferon's Encapsulation.
    Ramos TI; Villacis-Aguirre CA; Santiago Vispo N; Santiago Padilla L; Pedroso Santana S; Parra NC; Alonso JRT
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.